Albemarle Corp ALB.N reported a quarterly adjusted loss of 18 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 26 cents. The mean expectation of twenty analysts for the quarter was for a loss of 59 cents per share. Wall Street expected results to range from $-1.27 to 97 cents per share.
Revenue fell 20.9% to $1.08 billion from a year ago; analysts expected $1.16 billion.
Albemarle Corp's reported EPS for the quarter was breakeven results.
The company reported a quarterly loss of $340 thousand.
Albemarle Corp shares had fallen by 17.4% this quarter and lost 30.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 50.3% in the last three months.
In the last 30 days, seven analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy," 17 "hold" and 3 "sell" or "strong sell." The average consensus recommendation for the specialty chemicals peer group is also "hold"
Wall Street's median 12-month price target for Albemarle Corp is $83.28
This summary was machine generated from LSEG data April 30 at 09:02 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Mar. 31 2025 | -0.59 | -0.18 | Beat |
Dec. 31 2024 | -0.70 | -1.09 | Missed |
Sep. 30 2024 | -0.44 | -1.55 | Missed |
Jun. 30 2024 | 0.41 | 0.04 | Missed |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.